Heart valve tissue engineering

Transplant Immunology

Volumn 12, Issue 3-4, 2004, Pages 359-365

  Neuenschwander, Stefan ^a   Hoerstrup, Simon P ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Autologous; Biodegradable polymer; Cardiovascular; Tissue engineered heart valve

Indexed keywords

POLYMER;

ALLOGRAFT; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BLOOD; BONE MARROW CELL; CELL LINEAGE; FEASIBILITY STUDY; HEART SURGERY; HEART VALVE; MORBIDITY; PRIORITY JOURNAL; REVIEW; STEM CELL; TISSUE ENGINEERING; VALVULAR HEART DISEASE; XENOGRAFT;

EID: 2442609753     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2003.12.010     Document Type: Article

References (50)

1. Schoen F.J. Aortic valve structure-function correlations: role of elastic fibers no longer a stretch of the imagination. J Heart Valve Dis. 6:(1):1997;1-6
2. Hammermeister K.E., Sethi G.K., Henderson W.G., Oprian C., Kim T., Rahimtoola S. A comparison of outcomes in men 11 years after heart-valve replacement with a mechanical valve or bioprosthesis. Veterans Affairs Cooperative Study on Valvular Heart Disease. N Engl J Med. 328:(18):1993;1289- 1296
3. Vongpatanasin W., Hillis L.D., Lange R.A. Prosthetic heart valves. N Engl J Med. 335:(6):1996;407-416
4. Schmidt C.E., Baier J.M. Acellular vascular tissues: natural biomaterials for tissue repair and tissue engineering. Biomaterials. 21:(22):2000;2215-2231
5. Mayer J.E. Jr. Uses of homograft conduits for right ventricle to pulmonary artery connections in the neonatal period. Semin Thorac Cardiovasc Surg. 7:(3):1995;130-132
6. Shinoka T., Breuer C.K., Tanel R.E., et al. Tissue engineering heart valves: valve leaflet replacement study in a lamb model. Ann Thorac Surg. 60:(6 Suppl):1995;S513-S516
7. Shinoka T., Ma P.X., Shum-Tim D., et al. Tissue-engineered heart valves. Autologous valve leaflet replacement study in a lamb model. Circulation. 94:(9 Suppl):1996;I164-I168
8. Zund G., Breuer C.K., Shinoka T., et al. The in vitro construction of a tissue engineered bioprosthetic heart valve. Eur J Cardiothorac Surg. 11:(3):1997;493-497
9. Hoerstrup S.P., Sodian R., Daebritz S., et al. Functional living trileaflet heart valves grown in vitro. Circulation. 102:(19 Suppl 3):2000;III44-III49
10. Hoerstrup S.P., Kadner A., Melnitchouk S., et al. Tissue engineering of functional trileaflet heart valves from human marrow stromal cells. Circulation. 106:(12 Suppl 1):2002;I143-I150
11. Hubbell J.A., Massia S.P., Desai N.P., Drumheller P.D. Endothelial cell-selective materials for tissue engineering in the vascular graft via a new receptor. Biotechnology (N Y). 9:(6):1991;568-572
12. Zisch AH, Lutolf MP, Ehrbar M, et al. Cell-demanded release of VEGF from synthetic, biointeractive cell-ingrowth matrices for vascularized tissue growth. Faseb J 2003:(in press)
13. Badylak S.F. The extracellular matrix as a scaffold for tissue reconstruction. Semin Cell Dev Biol. 13:(5):2002;377-383
14. Bader A., Schilling T., Teebken O.E., et al. Tissue engineering of heart valves - human endothelial cell seeding of detergent acellularized porcine valves. Eur J Cardiothorac Surg. 14:(3):1998;279-284
15. Zeltinger J., Landeen L.K., Alexander H.G., Kidd I.D., Sibanda B. Development and characterization of tissue-engineered aortic valves. Tissue Eng. 7:(1):2001;9-22
16. Dohmen P.M., Ozaki S., Verbeken E., Yperman J., Flameng W., Konertz W.F. Tissue engineering of an auto-xenograft pulmonary heart valve. Asian Cardiovasc Thorac Ann. 10:(1):2002;25-30
17. O'Brien M.F., Goldstein S., Walsh S., Black K.S., Elkins R., Clarke D. The SynerGraft valve: a new acellular (non-glutaraldehyde-fixed) tissue heart valve for autologous recellularization first experimental studies before clinical implantation. Semin Thorac Cardiovasc Surg. 11:(4 Suppl 1):1999;194-200
18. Elkins R.C., Goldstein S., Hewitt C.W., et al. Recellularization of heart valve grafts by a process of adaptive remodeling. Semin Thorac Cardiovasc Surg. 13:(4 Suppl 1):2001;87-92
19. Elkins R.C., Dawson P.E., Goldstein S., Walsh S.P., Black K.S. Decellularized human valve allografts. Ann Thorac Surg. 71:(5 Suppl):2001;S428-S432
20. Elkins R.C. Is tissue-engineered heart valve replacement clinically applicable? Curr Cardiol Rep. 5:(2):2003;125-128
21. Simon P., Kasimir M.T., Seebacher G., et al. Early failure of the tissue engineered porcine heart valve SYNERGRAFT in pediatric patients. Eur J Cardiothorac Surg. 23:(6):2003;1002-1006
22. Martin U., Kiessig V., Blusch J.H., et al. Expression of pig endogenous retrovirus by primary porcine endothelial cells and infection of human cells. Lancet. 352:(9129):1998;692-694
23. Walles T., Lichtenberg A., Puschmann C., et al. In vivo model for cross-species porcine endogenous retrovirus transmission using tissue engineered pulmonary arteries. Eur J Cardiothorac Surg. 24:(3):2003;358-363
24. Lehner G., Fischlein T., Baretton G., Murphy J.G., Reichart B. Endothelialized biological heart valve prostheses in the non-human primate model. Eur J Cardiothorac Surg. 11:(3):1997;498-504
25. Trantina-Yates A.E., Human P., Bracher M., Zilla P. Mitigation of bioprosthetic heart valve degeneration through biocompatibility: in vitro vs. spontaneous endothelialization. Biomaterials. 22:(13):2001;1837-1846
26. Gulbins H., Goldemund A., Anderson I., et al. Preseeding with autologous fibroblasts improves endothelialization of glutaraldehyde-fixed porcine aortic valves. J Thorac Cardiovasc Surg. 125:(3):2003;592-601
27. Jansson K., Bengtsson L., Swedenborg J., Haegerstrand A. In vitro endothelialization of bioprosthetic heart valves provides a cell monolayer with proliferative capacities and resistance to pulsatile flow. J Thorac Cardiovasc Surg. 121:(1):2001;108-115
28. Carnagey J., Hern-Anderson D., Ranieri J., Schmidt C.E. Rapid endothelialization of PhotoFix natural biomaterial vascular grafts. J Biomed Mater Res. 65B:(1):2003;171-179
29. Wissink M.J., van Luyn M.J., Beernink R., et al. Endothelial cell seeding on crosslinked collagen: effects of crosslinking on endothelial cell proliferation and functional parameters. Thromb Haemost. 84:(2):2000;325-331
30. Cheung D.T., Weber P.A., Grobe A.C., et al. A new method for the preservation of aortic valve homografts. J Heart Valve Dis. 10:(6):2001;728-734
31. Sodian R., Hoerstrup S.P., Sperling J.S., et al. Early in vivo experience with tissue-engineered trileaflet heart valves. Circulation. 102:(19 Suppl 3):2000;III22-III29
32. Sodian R., Hoerstrup S.P., Sperling J.S., et al. Evaluation of biodegradable, three-dimensional matrices for tissue engineering of heart valves. Asaio J. 46:(1):2000;107-110
33. Niklason L.E., Langer R.S. Advances in tissue engineering of blood vessels and other tissues. Transpl Immunol. 5:(4):1997;303-306
34. Niklason L.E., Gao J., Abbott W.M., et al. Functional arteries grown in vitro. Science. 284:(5413):1999;489-493
35. Hoerstrup S.P., Sodian R., Sperling J.S., Vacanti J.P., Mayer J.E. Jr. New pulsatile bioreactor for in vitro formation of tissue engineered heart valves. Tissue Eng. 6:(1):2000;75-79
36. Hoerstrup S.P., Zund G., Schoeberlein A., Ye Q., Vogt P.R., Turina M.I. Fluorescence activated cell sorting: a reliable method in tissue engineering of a bioprosthetic heart valve. Ann Thorac Surg. 66:(5):1998;1653-1657
37. Schnell A.M., Hoerstrup S.P., Zund G., et al. Optimal cell source for cardiovascular tissue engineering: venous vs. aortic human myofibroblasts. Thorac Cardiovasc Surg. 49:(4):2001;221-225
38. Roy A., Brand N.J., Yacoub M.H. Molecular characterization of interstitial cells isolated from human heart valves. J Heart Valve Dis. 9:(3):2000;459-464
39. Prockop D.J. Marrow stromal cells as stem cells for non-hematopoietic tissues. Science. 276:(5309):1997;71-74
40. Orlic D., Kajstura J., Chimenti S., et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci USA. 98:(18):2001;10 344-10 349
41. Orlic D., Kajstura J., Chimenti S., et al. Bone marrow cells regenerate infarcted myocardium. Nature. 410:(6829):2001;701-705
42. Sata M., Saiura A., Kunisato A., et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med. 8:(4):2002;403-409
43. Kadner A., Hoerstrup S.P., Zund G., et al. A new source for cardiovascular tissue engineering: human bone marrow stromal cells. Eur J Cardiothorac Surg. 21:(6):2002;1055-1060
44. Perry T.E., Kaushal S., Sutherland F.W., et al. Thoracic Surgery Directors Association Award. Bone marrow as a cell source for tissue engineering heart valves. Ann Thorac Surg. 75:(3):2003;761-767
45. Taylor P.M., Allen S.P., Dreger S.A., Yacoub M.H. Human cardiac valve interstitial cells in collagen sponge: a biological three-dimensional matrix for tissue engineering. J Heart Valve Dis. 11:(3):2002;298-306
46. Reyes M., Lund T., Lenvik T., Aguiar D., Koodie L., Verfaillie C.M. Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood. 98:(9):2001;2615-2625
47. Reyes M., Dudek A., Jahagirdar B., Koodie L., Marker P.H., Verfaillie C.M. Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest. 109:(3):2002;337-346
48. Kaushal S., Amiel G.E., Guleserian K.J., et al. Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo. Nat Med. 7:(9):2001;1035-1040
49. Dvorin E.L., Wylie-Sears J., Kaushal S., Martin D.P., Bischoff J. Quantitative evaluation of endothelial progenitors and cardiac valve endothelial cells: proliferation and differentiation on poly-glycolic acid/poly-4- hydroxybutyrate scaffold in response to vascular endothelial growth factor and transforming growth factor beta1. Tissue Eng. 9:(3):2003;487-493
50. Zhao Y., Glesne D., Huberman E. A human peripheral blood monocyte-derived subset acts as pluripotent stem cells. Proc Natl Acad Sci USA. 100:(5):2003;2426-2431